We share a common vision with AstraZeneca for how mRNA therapeutics will enable many new innovative drugs for targets which are totally undruggable today. We look forward to this unique ...

"All we have to go on is a limited data release. The protection from the Oxford AstraZeneca vaccine may be less than that from the mRNA vaccines, but we need to wait and see. "It is remarkable ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, that experts coined a new medical term: vaccine-induced thrombosis with ...

AstraZeneca and its biologics research arm MedImmune have signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.

COVID-19 vaccine DNA contamination claims aren't new, but have resurfaced in the wake of a Canadian study that some ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably ... A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Moderna is advancing mRNA therapeutics for cardiometabolic disease, immuno-oncology, and rare diseases, among other indications. The company also has existing partnerships with AstraZeneca ...

Vaxzevria, AstraZeneca's 'viral vector' COVID-19 vaccine, was battling perception issues, with stakeholders holding the misconception that mRNA COVID-19 vaccines were more effective in preventing the ...

"Our study provides compelling evidence that repeated mRNA vaccinations can improve ... Ablynx, ALK, ArgenX, AstraZeneca, Bekaert Textiles, Genentech, GSK, Hall Allergy, Medtronic, Novartis ...

Without the Oxford/AstraZeneca vaccine there would have been many more deaths from Covid,' he said. 'The mRNA vaccines (made by Pfizer and Moderna) could not have been available in sufficient ...